Spineart is a medical technology company focused on creating and advancing innovations for spine surgery. Its work centers on improving procedures and outcomes within spinal care through new surgical solutions. The company recently secured fresh capital to intensify its innovation efforts. Specifically, Spineart raised $31 million, indicating investor confidence in its strategy and market potential. The new funding strengthens its cash position and enables the firm to accelerate development and deployment of its spine-surgery offerings. Although exact operating metrics were not disclosed, the financing underscores the company’s commitment to scaling its innovation pipeline.

Total raised

$140M

Funding rounds

4

Latest round

Equity

Latest activity

Sep 2025